Nearly 700 New Medications In Development To Treat Diseases Affecting Blacks
Drug companies are working on 691 new medicines that treat diseasesdisproportionately affecting blacks, according to a report issued bythe Pharmaceutical Research and Manufacturers of America, the Memphis Business Journal reports.
According to the report,
- 229 of the drugs are for cancers that disproportionately affect blacks;
- 114 address cardiovascular disease;
- 95 are to treat diabetes;
- 77 are for respiratory conditions, including asthma;
- 67 target HIV; and
- Other treatments will address kidney disease, glaucoma, obesity and sickle cell disease.
PhRMAPresident and CEO Billy Tauzin said in a statement, "There are complexreasons for the health disparity between African-Americans and otherAmericans that are not fully understood. These 691 medicines indevelopment offer hope for closing the troubling health gap andincrease the likelihood that every American can share in the benefitsof medical progress" (Memphis Business Journal, 12/10).
Thereport was delivered to Mississippi Gov. Haley Barbour (R). Mississippihas the largest population of blacks in the U.S., according to the U.S.Census Bureau.
PhRMASenior Vice President Ken Johnson said, "The diseases highlighted inthe report ... are among the diseases that disproportionately affectAfrican-Americans in Mississippi" (PhRMA release, 12/10).
Reprinted with permission from kaisernetwork.org. You can view theentire Kaiser WeeklyHealth Disparities Report,search the archives, and sign up for email delivery at kaisernetwork.org/email. The Kaiser Weekly HealthDisparities Report is published for kaisernetwork.org, a free service of TheHenry J. Kaiser Family Foundation.